Journal
CLINICAL & TRANSLATIONAL ONCOLOGY
Volume 14, Issue 6, Pages 486-488Publisher
SPRINGER
DOI: 10.1007/s12094-012-0828-9
Keywords
Breast cancer subtypes; Predictive factors; Neoadjuvant chemotherapy; Magnetic resonance imaging
Categories
Ask authors/readers for more resources
Changes in magnetic resonance imaging (MRI) during neoadjuvant chemotherapy (NAC) have been reported as predictive of pathology outcome in triple-negative and HER2-positive breast cancer. The purpose of our study was to evaluate the relevance of breast cancer subtype for MRI response in 24 women before and during NAC in our centre. Our results show that a reduction greater than 23% is associated with a pathological complete response (pCR) in Her-2-positive and ER-negative/Her2-negative breast cancer, and suggest a trend correlation between higher ADC values and pCR in these subtypes in comparison with ER-positive/Her2-negative breast cancers. Higher proliferating tumours respond better to chemotherapy and our study suggests that changes in MRI during NAC are predictive of pCR in these breast cancer subtypes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available